This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Cardiogenic shock (CS) induced by severe aorticstenosis (AS) is a life-threatening condition with high mortality. Results Seventeen studies were included, totalling 2811 patients. These findings offer critical insights for clinical decision-making optimising patientcare in this critically ill population.
EchoSolv, the groundbreaking AI platform developed by Echo IQ, is revolutionizing the detection of aorticstenosis. With its unparalleled access to extensive echocardiographic data and AI-driven analysis, EchoSolv empowers clinicians to identify aorticstenosis earlier and with greater accuracy.
24 and how those may impact clinical practice and patientcare in this deep dive clinical trial session. 24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m. ET Murphy Ballroom 4 ACC.24
Through real multi-specialty collaboration, this summit will not only advance our knowledge but also directly impact patientcare worldwide." Our goal is to unite specialists from every corner of cardiovascular care to extend the heart team, redefine innovations, and develop new standards for managing valve patients."
Through real multi-specialty collaboration, this summit will not only advance our knowledge but also directly impact patientcare worldwide." Our goal is to unite specialists from every corner of cardiovascular care to extend the heart team, redefine innovations, and develop new standards for managing valve patients."
Their teamwork and collaboration, allows us to advance collective efforts within this sector, driving forward innovation and enhancing patientcare," said SCAI Interventional Cardiology Program Chair, J. About 276,000 patients have undergone a TAVR procedure in the United States.
Aortic Dissection, Valvular (especially AorticStenosis), Tamponade. Check : [vitals, SOB, Chest Pain, Ultrasound] If the patient has Abdominal Pain, Chest Pain, Dyspnea or Hypoxemia, Headache, Hypotension , then these should be considered the primary chief complaint (not syncope). heart auscultation (aorticstenosis); c.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content